查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1726309

全球腸道疾病檢測市場：市場規模、佔有率、趨勢分析（按疾病和地區）、細分市場預測（2025-2030 年）

Enteric Disease Testing Market Size, Share, & Trends Analysis Report By Disease (Bacterial, Viral, Parasitic), By Region (North America, Europe, Asia Pacific, Latin America, MEA), And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

腸病檢測市場的成長與趨勢：

根據Grand View Research, Inc.的最新報告，全球腸道疾病檢測市場規模預計到2030年將達到47.4億美元，2025年至2030年期間的複合年成長率為3.1%。

腸道疾病盛行率的不斷上升和先進診斷技術的不斷普及是推動市場成長的主要因素。根據美國疾病管制與預防中心的數據，全球每年記錄的傷寒病例接近1,100萬例，副傷寒病例約500萬例。

生活方式和消費者偏好的改變導致多個地區胃腸道感染疾病發病率的增加，從而推動了對腸道疾病檢測解決方案的需求。人們越來越意識到，如果不及時干預，腸道疾病可能會造成嚴重後果，因此檢測數量正在增加。多個政府機構對保護公眾健康和預防疫情的重視也有望在未來幾年推動該產業的發展。

政府改善醫療保健的措施（如篩檢計劃、宣傳宣傳活動和特定福利計劃）預計將推動市場成長。例如，在美國，疾病管制與預防中心（CDC）使用腸道疾病反應、調查和協調系統（SEDRIC）有效監測和應對與食品和動物接觸有關的疾病爆發。他們還幫助管理 BEAM（細菌、腸道細菌、變形蟲、真菌）儀表板，向大眾提供腸道疾病爆發數據。預計此類努力將導致預測期內進行的測試數量增加。

腸病檢測市場：概述

  • 2024 年，細菌類藥物佔據腸道疾病檢測市場的 60% 左右，這是因為大腸桿菌、大腸桿菌性結腸炎、志賀氏菌和沙門氏菌等大量細菌會導致常見的腸道疾病。
  • 由於受污染的水和食物、各地區衛生系統差以及缺乏適當的衛生條件而導致的腸道疾病病例不斷增加，寄生蟲學領域預計將會成長。
  • 各國政府越來越重視提供採用先進診斷技術的優質醫療服務，以防止疫情大規模爆發，預計將創造成長機會。
  • 由於強大的醫療保健基礎設施、主要診斷技術開發商和生物技術公司的存在等因素，北美在 2024 年佔據了全球產業的主導地位。
  • 預計區域機構和政府資助的研究計畫的預防工作將刺激成長。
  • 2025年2月，生物梅里埃宣布其新的檢測解決方案BIOFIRE FILMARRAY胃腸道（GI）面板Mid.已獲得美國FDA批准。

目錄

第1章 分析方法與範圍

第2章執行摘要

3. 腸道疾病檢測市場：促進因素、趨勢與範圍

  • 市場聯動展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制分析
  • 腸道疾病檢測市場：分析工具
    • 產業分析：波特五力分析
    • PESTEL分析

第4章腸道疾病檢測市場：依疾病的估計與趨勢分析

  • 特定疾病的儀表板
  • 腸病檢測市場：產業趨勢分析
  • 全球腸病檢測市場：按疾病分類的市場規模和趨勢分析（2018-2030 年）
  • 細菌
    • 市場估計與預測（2018-2030）
    • 艱難梭菌
    • 曲狀桿菌
    • 霍亂
    • 大腸桿菌
    • 幽門螺旋桿菌
    • 沙門氏菌病
    • 志賀氏菌症
  • 病毒
    • 市場估計與預測（2018-2030）
    • 輪狀病毒
    • 諾羅病毒
  • 寄生蟲
    • 市場估計與預測（2018-2030）
    • 阿米巴病
    • 隱孢子蟲病
    • 賈第鞭毛蟲病

第5章腸道疾病檢測市場：按地區估計和趨勢分析

  • 市場儀表板：按地區
  • 各地區市場佔有率分析（2024 年及 2030 年）
  • 腸病檢測市場：按地區分類的關鍵要點
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第6章 競爭態勢

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商格局
    • 主要企業熱力圖分析（2024年）
  • 公司簡介
    • Abbott
    • BD
    • Biomerica
    • BIOMERIEUX
    • Bio-Rad Laboratories, Inc.
    • Cepheid
    • Coris Bioconcept
    • DiaSorin SpA
    • Meridian Bioscience
    • Quest Diagnostics Incorporated
Product Code: GVR-1-68038-542-7

Enteric Disease Testing Market Growth & Trends:

The global enteric disease testing market size is anticipated to reach USD 4.74 billion by 2030 and is anticipated to expand at a CAGR of 3.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. The increasing incidence of enteric diseases and the rising adoption of advanced diagnostic technologies are the major factors contributing to market growth. According to the U.S. Center for Disease Control and Prevention, nearly 11 and 21 million cases of typhoid fever and approximately 5 million paratyphoid fever cases are recorded worldwide each year.

The increasing incidence of gastrointestinal infections in multiple regions, driven by changing lifestyles and consumer preferences, has generated greater demand for enteric disease testing solutions. Growing awareness regarding the severe effects of enteric diseases, if not intervened in time, has led to the rising number of tests. The focus of multiple government agencies on protecting public health and preventing outbreaks is also expected to drive the growth of this industry in the coming years.

Government initiatives for improved healthcare, including screening programs, awareness campaigns, and specific welfare schemes, are projected to fuel market growth. For instance, in the U.S., the Centers for Disease Control and Prevention (CDC) uses the System for Enteric Disease Response, Investigation, and Coordination (SEDRIC) to ensure efficient surveillance and response to disease outbreaks linked to food or animal contact. It also helps manage the BEAM (Bacteria, Enterics, Ameba, and Mycotics) Dashboard, which provides enteric disease outbreak data to public viewers. Such initiatives are expected to result in increased testing in the forecast period.

Enteric Disease Testing Market Report Highlights:

  • The bacterial segment dominated the enteric disease testing market with nearly 60% share in 2024 owing to many bacteria, such as C. difficile, E. coli, Shigella, and Salmonella, which cause common enteric diseases.
  • The parasitic segment is expected to experience growth due to increasing cases of enteric diseases driven by contaminated water and food, poor sanitation systems in various regions, and lack of adequate hygiene.
  • The growing focus of multiple governments on offering improved healthcare services that feature advanced diagnostic technologies to prevent large-scale outbreaks is expected to create growth opportunities.
  • North America dominated the global industry in 2024 owing to factors such as a robust healthcare infrastructure and the presence of key diagnostic technology developers and biotechnology companies.
  • Preventive measures embraced by local agencies and government-funded research programs are anticipated to fuel growth.
  • In February 2025, BIOMERIEUX announced that it received clearance from the U.S. FDA for its new testing solution, BIOFIRE FILMARRAY Gastrointestinal (GI) Panel Mid.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Disease Outlook
    • 1.2.2. Regional Scope
    • 1.2.3. Estimates and Forecasts Timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Disease Outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Enteric Diseases Testing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Enteric Diseases Testing Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis

Chapter 4. Enteric Diseases Testing: Disease Estimates & Trend Analysis

  • 4.1. Disease Segment Dashboard
  • 4.2. Enteric Diseases Testing Market: Industry Movement Analysis
  • 4.3. Global Enteric Diseases Testing Market Size & Trend Analysis, by Disease , 2018 to 2030 (USD Million)
  • 4.4. Bacterial
    • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. C. Difficile
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Campylobacteriosis
      • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Cholera
      • 4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.5. E. Coli
      • 4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.6. H. Pylori
      • 4.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.7. Salmonellosis
      • 4.4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.8. Shigellosis
      • 4.4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Viral
    • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.2. Rotavirus
      • 4.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.3. Norovirus
      • 4.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Parasitic
    • 4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.2. Amebiasis
      • 4.6.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.3. Cryptosporidiosis
      • 4.6.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.4. Giardiasis
      • 4.6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Enteric Diseases Testing Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Market Dashboard
  • 5.2. Regional Market Share Analysis, 2024 & 2030
  • 5.3. Continuous bioprocessing market by Region: Key Takeaways
  • 5.4. North America
    • 5.4.1. U.S.
      • 5.4.1.1. Key country dynamics
      • 5.4.1.2. Regulatory framework/ reimbursement structure
      • 5.4.1.3. Competitive scenario
      • 5.4.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Canada
      • 5.4.2.1. Key country dynamics
      • 5.4.2.2. Regulatory framework/ reimbursement structure
      • 5.4.2.3. Competitive scenario
      • 5.4.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Mexico
      • 5.4.3.1. Key country dynamics
      • 5.4.3.2. Regulatory framework/ reimbursement structure
      • 5.4.3.3. Competitive scenario
      • 5.4.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Europe
    • 5.5.1. UK
      • 5.5.1.1. Key country dynamics
      • 5.5.1.2. Regulatory framework/ reimbursement structure
      • 5.5.1.3. Competitive scenario
      • 5.5.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.2. Germany
      • 5.5.2.1. Key country dynamics
      • 5.5.2.2. Regulatory framework/ reimbursement structure
      • 5.5.2.3. Competitive scenario
      • 5.5.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.3. France
      • 5.5.3.1. Key country dynamics
      • 5.5.3.2. Regulatory framework/ reimbursement structure
      • 5.5.3.3. Competitive scenario
      • 5.5.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.4. Italy
      • 5.5.4.1. Key country dynamics
      • 5.5.4.2. Regulatory framework/ reimbursement structure
      • 5.5.4.3. Competitive scenario
      • 5.5.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.5. Spain
      • 5.5.5.1. Key country dynamics
      • 5.5.5.2. Regulatory framework/ reimbursement structure
      • 5.5.5.3. Competitive scenario
      • 5.5.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.6. Norway
      • 5.5.6.1. Key country dynamics
      • 5.5.6.2. Regulatory framework/ reimbursement structure
      • 5.5.6.3. Competitive scenario
      • 5.5.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.7. Sweden
      • 5.5.7.1. Key country dynamics
      • 5.5.7.2. Regulatory framework/ reimbursement structure
      • 5.5.7.3. Competitive scenario
      • 5.5.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.8. Denmark
      • 5.5.8.1. Key country dynamics
      • 5.5.8.2. Regulatory framework/ reimbursement structure
      • 5.5.8.3. Competitive scenario
      • 5.5.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Asia Pacific
    • 5.6.1. Japan
      • 5.6.1.1. Key country dynamics
      • 5.6.1.2. Regulatory framework/ reimbursement structure
      • 5.6.1.3. Competitive scenario
      • 5.6.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.2. China
      • 5.6.2.1. Key country dynamics
      • 5.6.2.2. Regulatory framework/ reimbursement structure
      • 5.6.2.3. Competitive scenario
      • 5.6.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.3. India
      • 5.6.3.1. Key country dynamics
      • 5.6.3.2. Regulatory framework/ reimbursement structure
      • 5.6.3.3. Competitive scenario
      • 5.6.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.4. Australia
      • 5.6.4.1. Key country dynamics
      • 5.6.4.2. Regulatory framework/ reimbursement structure
      • 5.6.4.3. Competitive scenario
      • 5.6.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.5. South Korea
      • 5.6.5.1. Key country dynamics
      • 5.6.5.2. Regulatory framework/ reimbursement structure
      • 5.6.5.3. Competitive scenario
      • 5.6.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.6. Thailand
      • 5.6.6.1. Key country dynamics
      • 5.6.6.2. Regulatory framework/ reimbursement structure
      • 5.6.6.3. Competitive scenario
      • 5.6.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Latin America
    • 5.7.1. Brazil
      • 5.7.1.1. Key country dynamics
      • 5.7.1.2. Regulatory framework/ reimbursement structure
      • 5.7.1.3. Competitive scenario
      • 5.7.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.7.2. Argentina
      • 5.7.2.1. Key country dynamics
      • 5.7.2.2. Regulatory framework/ reimbursement structure
      • 5.7.2.3. Competitive scenario
      • 5.7.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.8. MEA
    • 5.8.1. South Africa
      • 5.8.1.1. Key country dynamics
      • 5.8.1.2. Regulatory framework/ reimbursement structure
      • 5.8.1.3. Competitive scenario
      • 5.8.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.8.2. Saudi Arabia
      • 5.8.2.1. Key country dynamics
      • 5.8.2.2. Regulatory framework/ reimbursement structure
      • 5.8.2.3. Competitive scenario
      • 5.8.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.8.3. UAE
      • 5.8.3.1. Key country dynamics
      • 5.8.3.2. Regulatory framework/ reimbursement structure
      • 5.8.3.3. Competitive scenario
      • 5.8.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.8.4. Kuwait
      • 5.8.4.1. Key country dynamics
      • 5.8.4.2. Regulatory framework/ reimbursement structure
      • 5.8.4.3. Competitive scenario
      • 5.8.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Company/Competition Categorization
  • 6.3. Vendor Landscape
    • 6.3.1. Key company heat map analysis, 2024
  • 6.4. Company Profiles
    • 6.4.1. Abbott
      • 6.4.1.1. Company overview
      • 6.4.1.2. Financial performance
      • 6.4.1.3. Product benchmarking
      • 6.4.1.4. Strategic initiatives
    • 6.4.2. BD
      • 6.4.2.1. Company overview
      • 6.4.2.2. Financial performance
      • 6.4.2.3. Product benchmarking
      • 6.4.2.4. Strategic initiatives
    • 6.4.3. Biomerica
      • 6.4.3.1. Company overview
      • 6.4.3.2. Financial performance
      • 6.4.3.3. Product benchmarking
      • 6.4.3.4. Strategic initiatives
    • 6.4.4. BIOMERIEUX
      • 6.4.4.1. Company overview
      • 6.4.4.2. Financial performance
      • 6.4.4.3. Product benchmarking
      • 6.4.4.4. Strategic initiatives
    • 6.4.5. Bio-Rad Laboratories, Inc.
      • 6.4.5.1. Company overview
      • 6.4.5.2. Financial performance
      • 6.4.5.3. Product benchmarking
      • 6.4.5.4. Strategic initiatives
    • 6.4.6. Cepheid
      • 6.4.6.1. Company overview
      • 6.4.6.2. Financial performance
      • 6.4.6.3. Product benchmarking
      • 6.4.6.4. Strategic initiatives
    • 6.4.7. Coris Bioconcept
      • 6.4.7.1. Company overview
      • 6.4.7.2. Financial performance
      • 6.4.7.3. Product benchmarking
      • 6.4.7.4. Strategic initiatives
    • 6.4.8. DiaSorin S.p.A.
      • 6.4.8.1. Company overview
      • 6.4.8.2. Financial performance
      • 6.4.8.3. Product benchmarking
      • 6.4.8.4. Strategic initiatives
    • 6.4.9. Meridian Bioscience
      • 6.4.9.1. Company overview
      • 6.4.9.2. Financial performance
      • 6.4.9.3. Product benchmarking
      • 6.4.9.4. Strategic initiatives
    • 6.4.10. Quest Diagnostics Incorporated
      • 6.4.10.1. Company overview
      • 6.4.10.2. Financial performance
      • 6.4.10.3. Product benchmarking
      • 6.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America enteric disease testing market, by country, 2018 - 2030 (USD Million)
  • Table 3 North America enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 4 U.S. enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 5 Canada enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 6 Mexico enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 7 Europe enteric disease testing market, by country, 2018 - 2030 (USD Million)
  • Table 8 Europe enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 9 UK enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 10 Germany enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 11 France enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 12 Italy enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 13 Spain enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 14 Denmark enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 15 Sweden enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 16 Norway enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 17 Asia Pacific enteric disease testing market, by country, 2018 - 2030 (USD Million)
  • Table 18 Asia Pacific enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 19 China enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 20 Japan enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 21 India enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 22 Australia enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 23 South Korea enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 24 Thailand enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 25 Latin America enteric disease testing market, by country, 2018 - 2030 (USD Million)
  • Table 26 Latin America enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 27 Brazil enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 28 Argentina enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 29 Middle East & Africa enteric disease testing market, by country, 2018 - 2030 (USD Million)
  • Table 30 Middle East & Africa enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 31 South Africa enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 32 Saudi Arabia enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 33 UAE enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 34 Kuwait enteric disease testing market, by disease, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Enteric disease testing market: market outlook
  • Fig. 10 Enteric disease competitive insights
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Penetration and growth prospect mapping
  • Fig. 14 Industry value chain analysis
  • Fig. 15 Enteric disease testing market driver impact
  • Fig. 16 Enteric disease testing market restraint impact
  • Fig. 17 Enteric disease testing market strategic initiatives analysis
  • Fig. 18 Global enteric disease testing market: Disease movement analysis
  • Fig. 19 Global enteric disease testing market: Disease outlook and key takeaways
  • Fig. 20 Bacterial enteric disease testing market estimates and forecast, 2018 - 2030
  • Fig. 21 Viral enteric disease testing market estimates and forecast, 2018 - 2030
  • Fig. 22 Rotavirus testing market estimates and forecast, 2018 - 2030
  • Fig. 23 Norovirus testing market estimates and forecast, 2018 - 2030
  • Fig. 24 Parasitic enteric disease testing market estimates and forecast, 2018-203
  • Fig. 25 Global enteric disease testing market: Regional movement analysis
  • Fig. 26 Global enteric disease testing market: Regional outlook and key takeaways
  • Fig. 27 North America enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 28 U.S. enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 29 Canada enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 30 Mexico enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 31 Europe enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 32 UK enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 33 Germany enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 34 France enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 35 Italy enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 36 Spain enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 37 Denmark enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 38 Sweden enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 39 Norway enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 40 Asia Pacific enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 41 China enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 42 Japan enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 43 India enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 44 Thailand enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 45 South Korea enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 46 Australia enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 47 Latin America enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 48 Brazil enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 49 Argentina enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 50 Middle East and Africa enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 51 South Africa enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 52 Saudi Arabia enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 53 UAE enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 54 Kuwait enteric disease testing market estimates and forecasts, 2018 - 2030